InsiderTrades.com logo

RARE Insider Trading

Insider Ownership Percentage: 5.20%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $3,353,766.38

Ultragenyx Pharmaceutical Insider Trading History Chart

This chart shows the insider buying and selling history at Ultragenyx Pharmaceutical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Ultragenyx Pharmaceutical Share Price & Price History

Current Price: $14.50
Price Change: ▲ Price Increase of +1.62 (12.58%)
As of 09/17/2026 04:00 PM ET

This chart shows the closing price history over time for RARE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Ultragenyx Pharmaceutical Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/15/2026Theodore Alan HuizengaCAOSell1,283$13.57$17,410.3167,863View SEC Filing Icon  
9/3/2026Theodore Alan HuizengaCAOSell161$13.99$2,252.3969,146View SEC Filing Icon  
6/15/2026Corsee D. SandersDirectorSell2,000$25.05$50,100.0021,095View SEC Filing Icon  
6/15/2026Karah Herdman ParschauerEVPSell1,899$24.62$46,753.3894,462View SEC Filing Icon  
6/1/2026Howard HornCFOSell4,653$23.77$110,601.81105,689View SEC Filing Icon  
5/18/2026Shehnaaz SulimanDirectorSell5,740$25.12$144,188.8027,951View SEC Filing Icon  
5/5/2026Eric CrombezEVPSell344$24.96$8,586.24111,189View SEC Filing Icon  
5/1/2026Howard HornCFOSell4,683$24.90$116,606.70110,342View SEC Filing Icon  
4/1/2026Howard HornCFOSell4,683$20.97$98,202.5180,351View SEC Filing Icon  
3/3/2026Howard HornCFOSell1,635$22.40$36,624.0085,034View SEC Filing Icon  
3/2/2026Emil D KakkisCEOSell54,404$22.80$1,240,411.20658,994View SEC Filing Icon  
3/2/2026Eric CrombezEVPSell7,029$22.80$160,261.2076,301View SEC Filing Icon  
3/2/2026Erik HarrisEVPSell10,539$22.80$240,289.2089,515View SEC Filing Icon  
3/2/2026Howard HornCFOSell8,409$22.70$190,884.3086,669View SEC Filing Icon  
3/2/2026John Richard PinionInsiderSell10,029$22.80$228,661.20110,026View SEC Filing Icon  
3/2/2026Karah Herdman ParschauerEVPSell8,135$22.80$185,478.0076,346View SEC Filing Icon  
3/2/2026Theodore Alan HuizengaCAOSell1,632$22.80$37,209.6048,670View SEC Filing Icon  
2/2/2026Howard HornCFOSell3,061$23.56$72,117.1688,935View SEC Filing Icon  
12/29/2025Theodore Alan HuizengaCAOSell85$34.38$2,922.3050,450View SEC Filing Icon  
12/10/2025Howard HornCFOSell3,081$36.38$112,086.7895,146View SEC Filing Icon  
10/13/2025Howard HornCFOSell7,942$31.51$250,252.4298,227View SEC Filing Icon  
9/18/2025Theodore Alan HuizengaCAOSell64$29.17$1,866.8850,242View SEC Filing Icon  
9/12/2025Karah Herdman ParschauerEVPSell2,450$31.17$76,366.5073,271View SEC Filing Icon  
6/20/2025Corsee D. SandersDirectorSell2,405$37.39$89,922.9515,344View SEC Filing Icon  
5/5/2025Eric CrombezEVPSell520$39.24$20,404.8071,530View SEC Filing Icon  
4/21/2025Eric CrombezEVPSell242$35.11$8,496.6271,680View SEC Filing Icon  
3/6/2025Howard HornCFOSell1,785$40.40$72,114.00106,169View SEC Filing Icon  
3/3/2025Emil D KakkisCEOSell73,434$42.10$3,091,571.40641,731View SEC Filing Icon  
3/3/2025John Richard PinionInsiderSell14,439$42.10$607,881.90107,766View SEC Filing Icon  
3/3/2025Theodore Alan HuizengaCAOSell967$42.10$40,710.7050,265View SEC Filing Icon  
3/3/2025Thomas Richard KassbergEVPSell6,028$42.10$253,778.80265,238View SEC Filing Icon  
2/28/2025Emil D KakkisCEOSell25,000$42.48$1,062,000.002,158,985View SEC Filing Icon  
2/27/2025Karah Herdman ParschauerEVPSell2,990$42.88$128,211.2054,991View SEC Filing Icon  
12/30/2024Emil D KakkisCEOSell11,727$42.23$495,231.212,183,985View SEC Filing Icon  
12/10/2024Emil D KakkisCEOSell8,273$50.00$413,650.002,195,712View SEC Filing Icon  
10/10/2024Howard HornCFOSell7,465$52.76$393,853.4092,301View SEC Filing Icon  
9/3/2024Emil D KakkisCEOSell20,000$55.85$1,117,000.002,223,985View SEC Filing Icon  
9/3/2024Theodore Alan HuizengaCAOSell91$56.19$5,113.2941,551View SEC Filing Icon  
8/6/2024Emil D KakkisCEOSell20,000$50.17$1,003,400.002,243,985View SEC Filing Icon  
7/2/2024Corsee D. SandersDirectorSell584$40.98$23,932.3212,009View SEC Filing Icon  
6/12/2024Karah Herdman ParschauerEVPSell9,806$45.00$441,270.0057,981View SEC Filing Icon  
6/10/2024Corsee D. SandersDirectorSell1,737$41.10$71,390.707,248View SEC Filing Icon  
4/18/2024Eric CrombezEVPSell142$44.10$6,262.2048,785View SEC Filing Icon  
3/11/2024Thomas Richard KassbergEVPSell11,509$49.93$574,644.37252,823View SEC Filing Icon  
3/7/2024Matthew K. FustDirectorSell12,195$50.88$620,481.6014,860View SEC Filing Icon  
3/1/2024John Richard PinionInsiderSell4,173$53.76$224,340.4889,268View SEC Filing Icon  
3/1/2024Karah Herdman ParschauerEVPSell3,756$53.76$201,922.5667,340View SEC Filing Icon  
3/1/2024Theodore Alan HuizengaCAOSell341$53.76$18,332.1641,380View SEC Filing Icon  
10/23/2023Thomas Richard KassbergEVPSell39,878$32.78$1,307,200.84246,860View SEC Filing Icon  
10/19/2023Emil D KakkisCEOSell47,853$33.52$1,604,032.56599,743View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Ultragenyx Pharmaceutical (NASDAQ:RARE)

97.67% of Ultragenyx Pharmaceutical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at RARE by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Ultragenyx Pharmaceutical Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/9/2026Engineers Gate Manager LP48,557$1.62M0.0%-45.7%0.049%Search for SEC Filing on Google Icon
9/9/2026Integrated Wealth Concepts LLC9,318$0.31M0.0%N/A0.009%Search for SEC Filing on Google Icon
9/9/2026IFP Advisors Inc2,313$77K0.0%+191.7%0.002%Search for SEC Filing on Google Icon
9/9/2026Squarepoint Ops LLC338,368$11.30M0.0%-23.9%0.343%Search for SEC Filing on Google Icon
9/8/2026Allworth Financial LP4,699$0.16M0.0%+130.9%0.005%Search for SEC Filing on Google Icon
9/8/2026Arizona State Retirement System23,059$0.77M0.0%-3.3%0.023%Search for SEC Filing on Google Icon
9/8/2026Nykredit A S4,615$0.15M0.0%N/A0.005%Search for SEC Filing on Google Icon
8/27/2026Corient Private Wealth LP146,493$4.89M0.0%+7.3%0.149%Search for SEC Filing on Google Icon
8/25/2026VIRGINIA RETIREMENT SYSTEMS ET Al31,019$1.04M0.0%N/A0.031%Search for SEC Filing on Google Icon
8/22/2026denkapparat Operations GmbH6,892$0.23M0.1%N/A0.007%Search for SEC Filing on Google Icon
8/21/2026AXQ Capital LP33,800$1.13M0.1%-64.9%0.034%Search for SEC Filing on Google Icon
8/21/2026Nykredit A S4,615$0.15M0.0%N/A0.005%Search for SEC Filing on Google Icon
8/20/2026Headlands Technologies LLC25,305$0.85M0.1%-50.2%0.026%Search for SEC Filing on Google Icon
8/20/2026Moore Capital Management LP128,035$4.28M0.1%-18.5%0.130%Search for SEC Filing on Google Icon
8/19/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC167,226$5.58M0.0%-25.0%0.170%Search for SEC Filing on Google Icon
8/19/2026Hsbc Holdings PLC45,174$1.53M0.0%-12.5%0.046%Search for SEC Filing on Google Icon
8/19/2026Wellington Management Group LLP1,250,464$41.75M0.0%-52.6%1.268%Search for SEC Filing on Google Icon
8/18/2026Palo Alto Investors LP596,495$19.92M0.0%N/A0.605%Search for SEC Filing on Google Icon
8/18/2026Jefferies Financial Group Inc.929,626$31.04M0.2%N/A0.943%Search for SEC Filing on Google Icon
8/17/2026Capstone Investment Advisors LLC16,457$0.55M0.0%N/A0.017%Search for SEC Filing on Google Icon
8/17/2026Corient Private Wealth LP139,094$4.64M0.0%N/A0.141%Search for SEC Filing on Google Icon
8/17/2026Bank of America Corp DE1,148,454$38.35M0.0%N/A1.165%Search for SEC Filing on Google Icon
8/15/2026Freestone Grove Partners LP1,861$62K0.0%N/A0.002%Search for SEC Filing on Google Icon
8/15/2026Odyssean LLC122,087$4.08M0.7%+81.1%0.124%Search for SEC Filing on Google Icon
8/15/2026Man Group plc195,110$6.52M0.0%N/A0.198%Search for SEC Filing on Google Icon
8/15/2026Jupiter Topco LLC36,543$1.22M0.0%N/A0.037%Search for SEC Filing on Google Icon
8/14/2026Hsbc Holdings PLC45,174$1.53M0.0%N/A0.046%Search for SEC Filing on Google Icon
8/14/2026PDT Partners LLC15,405$0.51M0.0%N/A0.016%Search for SEC Filing on Google Icon
8/14/2026Legal & General Group Plc586,520$19.58M0.0%N/A0.595%Search for SEC Filing on Google Icon
8/14/2026The Manufacturers Life Insurance Company381,420$12.74M0.0%N/A0.387%Search for SEC Filing on Google Icon
8/14/2026Algert Global LLC389,964$13.02M0.2%-9.0%0.396%Search for SEC Filing on Google Icon
8/13/2026Sanctuary Advisors LLC6,204$0.21M0.0%N/A0.006%Search for SEC Filing on Google Icon
8/13/2026Connor Clark & Lunn Investment Management Ltd.191,578$6.40M0.0%N/A0.194%Search for SEC Filing on Google Icon
8/12/2026Commerce Bank12,058$0.40M0.0%N/A0.012%Search for SEC Filing on Google Icon
8/12/2026Quantbot Technologies LP1,437$48K0.0%N/A0.001%Search for SEC Filing on Google Icon
8/12/2026Landscape Capital Management L.L.C.6,682$0.22M0.0%N/A0.007%Search for SEC Filing on Google Icon
8/12/2026Ieq Capital LLC106,026$3.54M0.0%N/A0.108%Search for SEC Filing on Google Icon
8/11/2026Allworth Financial LP4,699$0.16M0.0%N/A0.005%Search for SEC Filing on Google Icon
8/11/2026Blue Owl Capital Holdings LP182,638$6.10M0.9%N/A0.185%Search for SEC Filing on Google Icon
8/11/2026PCM Encore LLC6,306$0.21M0.0%N/A0.006%Search for SEC Filing on Google Icon
8/11/2026E Fund Management Co. Ltd.14,334$0.48M0.0%N/A0.015%Search for SEC Filing on Google Icon
8/10/2026Tocqueville Asset Management L.P.31,250$1.04M0.0%N/A0.032%Search for SEC Filing on Google Icon
8/10/2026Eagle Health Investments LP884,121$29.52M4.9%N/A0.897%Search for SEC Filing on Google Icon
8/7/2026BlackRock Inc.10,654,276$355.75M0.0%N/A10.818%Search for SEC Filing on Google Icon
8/7/2026Pallas Capital Advisors LLC8,602$0.29M0.0%N/A0.009%Search for SEC Filing on Google Icon
8/7/2026Deutsche Bank AG164,813$5.50M0.0%N/A0.167%Search for SEC Filing on Google Icon
8/7/2026Mitsubishi UFJ Asset Management Co. Ltd.10,437$0.35M0.0%N/A0.011%Search for SEC Filing on Google Icon
8/6/2026Bank of New York Mellon Corp470,697$15.72M0.0%N/A0.478%Search for SEC Filing on Google Icon
8/6/2026Focus Partners Advisor Solutions LLC9,791$0.33M0.0%N/A0.010%Search for SEC Filing on Google Icon
8/6/2026GSA Capital Partners LLP12,162$0.41M0.0%N/A0.012%Search for SEC Filing on Google Icon
8/3/2026Oppenheimer Asset Management Inc.6,604$0.22M0.0%N/A0.007%Search for SEC Filing on Google Icon
7/10/2026Handelsbanken Fonder AB39,523$1.32M0.0%+17.9%0.040%Search for SEC Filing on Google Icon
7/9/2026Hennion & Walsh Asset Management Inc.25,456$0.85M0.0%-57.8%0.026%Search for SEC Filing on Google Icon
7/8/2026Assenagon Asset Management S.A.120,864$4.04M0.0%-94.6%0.123%Search for SEC Filing on Google Icon
7/7/2026GAMMA Investing LLC1,919$64K0.0%+149.5%0.002%Search for SEC Filing on Google Icon
7/7/2026Harbor Investment Advisory LLC1,566$52K0.0%N/A0.002%Search for SEC Filing on Google Icon
7/2/2026Versant Capital Management Inc1,152$38K0.0%+662.9%0.001%Search for SEC Filing on Google Icon
6/3/2026Parallel Advisors LLC1,625$34K0.0%+778.4%0.002%Search for SEC Filing on Google Icon
5/19/2026Bank of America Corp DE1,046,546$21.93M0.0%-13.8%1.063%Search for SEC Filing on Google Icon
5/18/2026Amundi15,166$0.32M0.0%N/A0.015%Search for SEC Filing on Google Icon
5/18/2026EverSource Wealth Advisors LLC2,167$45K0.0%+573.0%0.002%Search for SEC Filing on Google Icon
5/18/2026California State Teachers Retirement System104,650$2.19M0.0%+25.6%0.106%Search for SEC Filing on Google Icon
5/18/2026Royal Bank of Canada3,295$69K0.0%-98.0%0.003%Search for SEC Filing on Google Icon
5/18/2026Rock Springs Capital Management LP1,218,773$25.53M1.5%-3.8%1.237%Search for SEC Filing on Google Icon
5/18/2026Eagle Health Investments LP884,121$18.52M3.2%N/A0.898%Search for SEC Filing on Google Icon
5/18/2026Eversept Partners LP62,575$1.31M0.1%-80.3%0.064%Search for SEC Filing on Google Icon
5/16/2026The Manufacturers Life Insurance Company451,119$9.45M0.0%+36.2%0.458%Search for SEC Filing on Google Icon
5/16/2026Quantinno Capital Management LP187,508$3.93M0.0%+276.9%0.190%Search for SEC Filing on Google Icon
5/16/2026SummitTX Capital L.P.347,760$7.29M0.2%N/A0.353%Search for SEC Filing on Google Icon
5/15/2026Entropy Technologies LP109,727$2.30M0.1%+80.9%0.111%Search for SEC Filing on Google Icon
5/14/2026Renaissance Technologies LLC561,700$11.77M0.0%+53.4%0.570%Search for SEC Filing on Google Icon
5/14/2026Pale Fire Capital SE16,514$0.35M0.0%+61.7%0.017%Search for SEC Filing on Google Icon
5/14/2026Public Employees Retirement System of Ohio26,832$0.56M0.0%-3.3%0.027%Search for SEC Filing on Google Icon
5/14/2026Knott David M Jr33,069$0.69M0.4%+65.3%0.034%Search for SEC Filing on Google Icon
5/14/2026Sei Investments Co.92,094$1.93M0.0%-40.1%0.094%Search for SEC Filing on Google Icon
5/13/2026First Trust Advisors LP14,198$0.30M0.0%-14.7%0.014%Search for SEC Filing on Google Icon
5/8/2026PNC Financial Services Group Inc.11,050$0.23M0.0%+66.2%0.011%Search for SEC Filing on Google Icon
5/7/2026Parallel Advisors LLC1,625$34K0.0%+778.4%0.002%Search for SEC Filing on Google Icon
5/5/2026Bank of New York Mellon Corp341,125$7.15M0.0%+14.2%0.347%Search for SEC Filing on Google Icon
5/1/2026Fifth Third Bancorp110,272$2.31M0.0%N/A0.112%Search for SEC Filing on Google Icon
5/1/2026Candriam S.C.A.1,096,182$22.97M0.1%+37.1%1.115%Search for SEC Filing on Google Icon
4/30/2026Hsbc Holdings PLC51,637$1.08M0.0%+74.0%0.053%Search for SEC Filing on Google Icon
4/27/2026Y Intercept Hong Kong Ltd218,354$4.58M0.1%N/A0.222%Search for SEC Filing on Google Icon
4/27/2026Leonteq Securities AG1,795$38K0.0%+288.5%0.002%Search for SEC Filing on Google Icon
4/27/2026Fideuram Intesa Sanpaolo Private Banking S.P.A.99,995$2.10M0.1%+63.0%0.102%Search for SEC Filing on Google Icon
4/22/2026Pictet Asset Management Holding SA603,571$11.67M0.0%-51.0%0.614%Search for SEC Filing on Google Icon
4/20/2026OP Asset Management Ltd86,917$1.82M0.0%N/A0.088%Search for SEC Filing on Google Icon
4/20/2026Assenagon Asset Management S.A.2,257,671$47.30M0.1%+1,030.4%2.297%Search for SEC Filing on Google Icon
4/16/2026SG Americas Securities LLC40,387$0.85M0.0%+25.4%0.041%Search for SEC Filing on Google Icon
3/20/2026Hsbc Holdings PLC29,679$0.66M0.0%-61.4%0.031%Search for SEC Filing on Google Icon
3/17/2026Rockefeller Capital Management L.P.7,716$0.18M0.0%+611.8%0.008%Search for SEC Filing on Google Icon
3/9/2026Flax Pond Capital LLC56,238$1.29M1.0%N/A0.058%Search for SEC Filing on Google Icon
3/3/2026Caitong International Asset Management Co. Ltd122,854$2.83M0.7%+1,116,754.5%0.127%Search for SEC Filing on Google Icon
2/19/2026Invesco Ltd.230,271$5.30M0.0%-71.0%0.239%Search for SEC Filing on Google Icon
2/19/2026Alberta Investment Management Corp38,400$0.88M0.0%N/A0.040%Search for SEC Filing on Google Icon
2/18/2026Mercer Global Advisors Inc. ADV13,965$0.32M0.0%+17.1%0.014%Search for SEC Filing on Google Icon
2/18/2026Krensavage Asset Management LLC149,634$3.44M1.2%N/A0.155%Search for SEC Filing on Google Icon
2/18/2026Empowered Funds LLC2,877$66K0.0%N/A0.003%Search for SEC Filing on Google Icon
2/18/2026XTX Topco Ltd119,996$2.76M0.1%+734.8%0.124%Search for SEC Filing on Google Icon
2/18/2026Voloridge Investment Management LLC643,356$14.80M0.1%+33.3%0.667%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Ultragenyx Pharmaceutical logo
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Japan, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia; Mepsevii, an enzyme replacement therapy for the treatment of children and adults with Mucopolysaccharidosis VII; Dojolvi for treating long-chain fatty acid oxidation disorders; and Evkeeza (evinacumab) for the treatment of homozygous familial hypercholesterolemia. The company's products candidatures include DTX401, an adeno-associated virus 8 (AAV8) gene therapy clinical candidate for the treatment of patients with glycogen storage disease type Ia; DTX301, an AAV8 gene therapy for the treatment of patients with ornithine transcarbamylase; UX143, a human monoclonal antibody for the treatment of osteogenesis imperfecta; GTX-102, an antisense oligonucleotide for the treatment of Angelman syndrome; UX111, an AAV9 gene therapy product candidate for the treatment of patients with Sanfilippo syndrome type A, or MPS IIIA, a rare lysosomal storage disease; UX701, for the treatment of Wilson disease; and UX053 for the treatment of glycogen storage disease type III. Ultragenyx Pharmaceutical Inc. has collaboration and license agreement with Kyowa Kirin Co., Ltd.; Saint Louis University; Baylor Research Institute; REGENXBIO Inc.; Bayer Healthcare LLC; GeneTx; Mereo; University of Pennsylvania; Arcturus Therapeutics Holdings Inc.; Solid Biosciences Inc.; Regeneron; Abeona; and Daiichi Sankyo Co., Ltd. The company was incorporated in 2010 and is headquartered in Novato, California.
Read More on Ultragenyx Pharmaceutical

Today's Range

Now: $14.50
Low: $13.20
High: $14.58

50 Day Range

MA: $24.26
Low: $12.88
High: $33.82

52 Week Range

Now: $14.50
Low: $12.73
High: $39.89

Volume

12,246,801 shs

Average Volume

4,983,745 shs

Market Capitalization

$1.43 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.31

Who are the company insiders with the largest holdings of Ultragenyx Pharmaceutical?

Ultragenyx Pharmaceutical's top insider shareholders include:
  1. Emil D Kakkis (CEO)
  2. Emil D Kakkis (CEO)
  3. Thomas Richard Kassberg (EVP)
  4. Shalini Sharp (CFO)
  5. Eric Crombez (EVP)
  6. Howard Horn (CFO)
  7. John Richard Pinion (Insider)
  8. Karah Herdman Parschauer (EVP)
  9. Erik Harris (EVP)
  10. Dennis Karl Huang (Insider)
Learn More about top insider investors at Ultragenyx Pharmaceutical.

Who are the major institutional investors of Ultragenyx Pharmaceutical?

Ultragenyx Pharmaceutical's top institutional investors include:
  1. BlackRock Inc. — 10.82%
  2. Wellington Management Group LLP — 1.27%
  3. Bank of America Corp DE — 1.16%
  4. Jefferies Financial Group Inc. — 0.94%
  5. Eagle Health Investments LP — 0.90%
  6. Palo Alto Investors LP — 0.61%
Learn More about top institutional investors of Ultragenyx Pharmaceutical stock.

Which major investors are selling Ultragenyx Pharmaceutical stock?

During the last quarter, RARE stock was sold by these institutional investors:
  1. Assenagon Asset Management S.A.
  2. Wellington Management Group LLP
  3. Squarepoint Ops LLC
  4. AXQ Capital LP
  5. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
  6. Engineers Gate Manager LP
  7. Algert Global LLC
  8. Hennion & Walsh Asset Management Inc.
During the previous year, company insiders that have sold Ultragenyx Pharmaceutical company stock include:
  1. Emil D Kakkis (CEO)
  2. Eric Crombez (EVP)
  3. Howard Horn (CFO)
  4. John Richard Pinion (Insider)
  5. Karah Herdman Parschauer (EVP)
  6. Erik Harris (EVP)
  7. Theodore Alan Huizenga (CAO)
  8. Shehnaaz Suliman (Director)
  9. Corazon (Corsee) D Sanders (Director)
Learn More investors selling Ultragenyx Pharmaceutical stock.

Which major investors are buying Ultragenyx Pharmaceutical stock?

During the last quarter, RARE stock was purchased by institutional investors including:
  1. BlackRock Inc.
  2. Bank of America Corp DE
  3. Jefferies Financial Group Inc.
  4. Eagle Health Investments LP
  5. Palo Alto Investors LP
  6. Legal & General Group Plc
  7. Bank of New York Mellon Corp
  8. The Manufacturers Life Insurance Company

Ultragenyx Pharmaceutical Active Insiders

Emil D. Kakkis
Emil D. Kakkis (Age 65)
CEO
Mardi Dier
Mardi Dier (Age 62)
CFO
Shalini Sharp
Shalini Sharp
CFO
Howard Horn
Howard Horn
CFO and EVP, Corporate Strategy
3 recent trades
Theodore Alan Huizenga
Theodore Alan Huizenga (Age 55)
CAO
2 recent trades
William Aliski
William Aliski
Director
Clay B Siegall
Clay B Siegall
Director
Corazon (Corsee) D Sanders
Corazon (Corsee) D Sanders
Director
1 recent trades
Matthew K Fust
Matthew K Fust
Director
Shehnaaz Suliman
Shehnaaz Suliman
Director
1 recent trades
Eric Crombez
Eric Crombez
Chief Medical Officer and EVP
1 recent trades
Erik Harris
Erik Harris (Age 56)
EVP
Dennis Karl Huang
Dennis Karl Huang (Age 61)
EVP
Karah Herdman Parschauer
Karah Herdman Parschauer (Age 48)
EVP
1 recent trades
Camille L Bedrosian
Camille L Bedrosian (Age 73)
EVP
Thomas Richard Kassberg
Thomas Richard Kassberg
EVP
John Richard Pinion
John Richard Pinion (Age 60)
Insider